Time to buy these 3 healthcare companies that raised revenue guidance?

Key PointsExact Sciences develops cancer detection and diagnostic tests like Cologuard.Hologic reported Q3 2023 17.5% organic revenue growth, excluding COVID-related revenues, which resulted in a drop of 5.5% year-over-year as normalization continues.Amicus Therapeutics develops treatments for rare diseases like Fabry and Pompe disease.5 stocks we like better than Exact SciencesThe new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous fo ...